Shenzhen YHLO Biotech Co., Ltd. (688575.SS)
CNY 14.94
(0.34%)
CNY 14.94
(0.34%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 96.2 Million CNY | 112.38% |
| 2022 | -777.01 Million CNY | -216.94% |
| 2021 | -245.16 Million CNY | -429.73% |
| 2020 | 74.35 Million CNY | -47.13% |
| 2019 | 140.63 Million CNY | -17.48% |
| 2018 | 170.42 Million CNY | 4092.68% |
| 2017 | -4.26 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 100.72 Million CNY | 4.7% |
| 2024 Q2 | 145.71 Million CNY | 44.67% |
| 2024 Q3 | 442.65 Million CNY | 205.7% |
| 2023 Q2 | 131.19 Million CNY | 147.76% |
| 2023 Q1 | -274.72 Million CNY | 64.64% |
| 2023 FY | 96.2 Million CNY | 112.38% |
| 2023 Q4 | 96.2 Million CNY | -45.29% |
| 2023 Q3 | 175.84 Million CNY | 34.03% |
| 2022 Q3 | -306.25 Million CNY | -12.05% |
| 2022 Q1 | -692.29 Million CNY | -182.38% |
| 2022 Q2 | -273.33 Million CNY | 60.52% |
| 2022 FY | -777.01 Million CNY | -216.94% |
| 2022 Q4 | -777.01 Million CNY | -153.71% |
| 2021 Q2 | -346.51 Million CNY | -264.17% |
| 2021 FY | -245.16 Million CNY | -429.73% |
| 2021 Q3 | -293.46 Million CNY | 15.31% |
| 2021 Q1 | 211.07 Million CNY | 183.88% |
| 2021 Q4 | -245.16 Million CNY | 16.46% |
| 2020 Q4 | 74.35 Million CNY | 0.0% |
| 2020 FY | 74.35 Million CNY | -47.13% |
| 2020 Q2 | 120.24 Million CNY | -20.2% |
| 2020 Q1 | 150.68 Million CNY | 7.15% |
| 2019 Q4 | 140.63 Million CNY | 0.0% |
| 2019 FY | 140.63 Million CNY | -17.48% |
| 2018 FY | 170.42 Million CNY | 4092.68% |
| 2017 FY | -4.26 Million CNY | 0.0% |